Market Research Logo

Blood Testing: Technology and Global Markets

CHAPTER 1 INTRODUCTION
STUDY OBJECTIVES
REASONS FOR DOING THIS STUDY
CONTRIBUTIONS OF THE STUDY AND FOR WHOM
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ANALYSTS' CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 EXECUTIVE SUMMARY
SUMMARY TABLE GLOBAL REVENUE FOR BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
SUMMARY FIGURE GLOBAL REVENUE FOR BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
CHAPTER 3 OVERVIEW
DEFINITIONS
BLOOD TEST
ANTIGEN
ANTIBODY
RED BLOOD CELLS
WHITE BLOOD CELLS
PLATELETS
PLASMA
BLOOD GROUP OR BLOOD TYPE
BLOOD TRANSFUSION
HISTORY OF BLOOD TESTING
TABLE 1 EVOLUTION OF BLOOD TRANSFUSION AND BLOOD TESTS
TESTING
TRADITIONAL TESTING
POINT-OF-CARE (POC) TESTING
TABLE 2 DIFFERENCES BETWEEN TRADITIONAL (MANUAL) BLOOD TESTING AND POINT-OF-CARE TESTING (AUTOMATIC)
BLOOD TESTS
DIAGNOSTIC TESTS
COMPLETE BLOOD COUNT
Total Red Blood Cell Count
Total White Blood Cell Count
Mean Corpuscular Volume (MCV)
Hemoglobin
Hematocrit
Hemoglobin A1c (HbA1c)
Mean Corpuscular Hemoglobin or Mean Corpuscular Hemoglobin Volume
COMPLETE BLOOD COUNT WITH DIFFERENTIAL AND PLATELET BLOOD TEST
Neutrophil Granulocytes
Lymphocytes
Monocytes
Eosinophil Granulocytes
Basophil Granulocytes
Platelets
TABLE 3 CONDITIONS ASSOCIATED WITH ABNORMALITIES OF ANALYTE OF COMPLETE BLOOD COUNT
ERYTHROCYTE SEDIMENTATION RATE (ESR)
ENZYME TEST
Troponin
Creatine Kinase (CK)
Lactate Dehydrogenase (LDH)
Alanine Transaminase (ALT) and Aspartate Transaminase (AST)
CLOTTING TEST OR COAGULATION TEST
Hemostasis
Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT)
Factor V Assay
Fibrinogen
Thrombin Time
ARTERIAL BLOOD GAS (ABG) TEST
SCREENING PANELS
SCREENING TESTS
CANCER SCREENING BLOOD TEST/CANCER BIOMARKER TEST
BLOOD GROUPING OR CROSS-MATCHING TEST
TABLE 4 BLOOD GROUP COMPATIBILITY
TABLE 5 PLASMA COMPATIBILITY
TOTAL PROTEIN TEST
A/G (Albumin/Globulin)
Total Bilirubin
GENERAL TOXICOLOGY AND DRUG-ABUSE TEST
Biomonitoring or Body Burden Test
Food Safe Allergy Test/Panel
LIPID PROFILE OR CHOLESTEROL TEST
Cholesterol Test
Cholesterol
C-Reactive Protein Test
COMPREHENSIVE METABOLIC PANEL
MONITORING TESTS
GENETIC TEST
BIOCHEMICAL TEST OR BASIC METABOLIC PANEL (BMP)
Diabetic Profile
Fluids and Electrolytes
Calcium
Kidney Profile
HORMONE TEST
METHODS OF EXTRACTION OF BLOOD FOR BLOOD TESTING
ADVANTAGES OF BLOOD TESTS
DISADVANTAGES OF BLOOD TESTS
TECHNOLOGY OUTLOOK FOR POINT-OF-CARE TESTING
POLYMERASE CHAIN REACTION (PCR)
TANDEM MASS SPECTROMETRY
MICROARRAY
GENE SEQUENCING OR DNA SEQUENCING
FLUORESCENCE IN SITU HYBRIDIZATION (FISH)
CHAPTER 4 REGULATORY ASPECTS
CLIA-WAIVED TESTS
RECENTLY APPROVED BLOOD TESTS, ASSAYS, KITS, AND DEVICES
TABLE 6 RECENT APPROVALS OF BLOOD TESTS, ASSAYS, KITS, AND MEDICAL DEVICES, 2010 TO SEPTEMBER 2014
RECENT APPROVALS OF MEDICAL DEVICES CLEARED THROUGH 510(K)
TABLE 7 RECENT APPROVALS OF MEDICAL DEVICES CLEARED THROUGH
510(K), 2010 TO SEPTEMBER 2014
APPROVALS OF CLIA-WAIVED BLOOD TESTS
TABLE 8 APPROVALS OF CLIA-WAIVED BLOOD TESTS, 2010 TO SEPTEMBER
2014
RECALLS
TABLE 9 RECALLS,2010 TO SEPTEMBER 2014
SAFETY ALERTS
TABLE 10 SAFETY ALERTS, 2010 TO SEPTEMBER 2014
CHAPTER 5 NEW DEVELOPMENTS
CLINICAL TRIALS OF BLOOD TESTS, ASSAYS AND KITS
TABLE 11 CLINICAL TRIALS IN BLOOD TESTS, ASSAYS AND KITS, 2010 TO SEPTEMBER 2014
MERGERS AND ACQUISITIONS
TABLE 12 MERGERS AND ACQUISITIONS OF TOP PHARMACEUTICAL COMPANIES, 2010 TO SEPTEMBER 2014
NEW PRODUCT LAUNCHES
TABLE 13 NEW PRODUCT LAUNCHES, 2012 TO SEPTEMBER 2014
NEW TECHNOLOGIES
CHAPTER 6 MARKET ANALYSIS
MARKET BY TYPE
MARKET OVERVIEW
MARKET REVENUE
TABLE 14 GLOBAL REVENUE FOR BLOOD TESTS BY TYPE, THROUGH 2019
FIGURE 1 GLOBAL REVENUE FOR BLOOD TESTS BY TYPE, 2012-2019 ($ MILLIONS)
MARKET SHARE
TABLE 15 MARKET SHARE OF BLOOD TESTS BY TYPE, 2013 (%)
FIGURE 2 MARKET SHARE OF BLOOD TESTS BY TYPE, 2013 (%)
MARKET BY REGION
MARKET OVERVIEW
MARKET REVENUE
TABLE 16 GLOBAL REVENUE FOR BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 3 GLOBAL REVENUE FOR BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
MARKET SHARE
TABLE 17 MARKET SHARE OF BLOOD TESTS BY REGION, 2013 (%)
FIGURE 4 MARKET SHARE OF BLOOD TESTS BY REGION, 2013 (%)
HEMATOLOGY BLOOD TESTS
Market Overview
Market Revenue
TABLE 18 GLOBAL REVENUE FOR HEMATOLOGY BLOOD TESTS BY TYPE, THROUGH 2019 ($ MILLIONS)
FIGURE 5 GLOBAL REVENUE FOR HEMATOLOGY BLOOD TESTS BY TYPE, 2012-2019 ($ MILLIONS)
Infectious Blood Tests
Market Overview
Market Revenue
TABLE 19 GLOBAL REVENUE FOR INFECTIOUS BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 6 GLOBAL REVENUE FOR INFECTIOUS BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
Blood Clotting Tests
Market Overview
Market Revenue
TABLE 20 GLOBAL REVENUE FOR BLOOD CLOTTING TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 7 GLOBAL REVENUE FOR BLOOD CLOTTING TESTS BY REGION, 2012-2019 ($ MILLIONS)
Complete Blood Count, Comprehensive Blood Tests, and Enzyme Blood
Tests
Market Overview
Market Revenue
TABLE 21 GLOBAL REVENUE FOR COMPLETE BLOOD COUNT, COMPREHENSIVE BLOOD TESTS, AND ENZYME BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 8 GLOBAL REVENUE FOR COMPLETE BLOOD COUNT, COMPREHENSIVE BLOOD TESTS, AND ENZYME BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
ONCOLOGY BLOOD TESTS (TUMOR/CANCER ASSAY TESTS)
Market Overview
Market Revenue
TABLE 22 GLOBAL REVENUE FOR CANCER/TUMOR ASSAY TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 9 GLOBAL REVENUE FOR CANCER/TUMOR ASSAY TESTS BY REGION, 2012-2019 ($ MILLIONS)
TOXICOLOGY BLOOD TESTS
Market Overview
Market Revenue
TABLE 23 GLOBAL REVENUE FOR TOXICOLOGY TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 10 GLOBAL REVENUE FOR TOXICOLOGY TESTS BY REGION, 2012-2019 ($ MILLIONS)
HEART PROFILE BLOOD TESTS
Market Overview
Market Revenue
TABLE 24 GLOBAL REVENUE FOR HEART PROFILE BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 11 GLOBAL REVENUE FOR HEART PROFILE BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
INFLAMMATION BLOOD TESTS
Market Overview
Market Revenue
TABLE 25 GLOBAL REVENUE FOR INFLAMMATION BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 12 GLOBAL REVENUE FOR INFLAMMATION BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
OTHERS CATEGORY OF BLOOD TESTS
Market Overview
Market Revenue
TABLE 26 GLOBAL REVENUE FOR OTHER BLOOD TESTS BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 13 GLOBAL REVENUE FOR OTHER BLOOD TESTS BY REGION, 2012-2019 ($ MILLIONS)
CHAPTER 7 INDUSTRY STRUCTURE
HEMATOLOGY
MARKET LEADERS
TABLE 27 LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN HEMATOLOGY BLOOD TESTING, 2013
MARKET SHARE
TABLE 28 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEMATOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
FIGURE 14 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEMATOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
HEART PROFILE
MARKET LEADERS
TABLE 29 LEADING MANUFACTURERS/ SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN HEART PROFILE BLOOD TESTING, 2013
MARKET SHARE
TABLE 30 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEART PROFILE BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013
FIGURE 15 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF HEART PROFILE BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
INFLAMMATION
MARKET LEADERS
TABLE 31 LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN INFLAMMATION BLOOD TESTING, 2013
MARKET SHARE
TABLE 32 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF INFLAMMATION BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
FIGURE 16 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF INFLAMMATION BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
ONCOLOGY
MARKET LEADERS
TABLE 33 LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN ONCOLOGY BLOOD TESTING, 2013
MARKET SHARE
TABLE 34 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF ONCOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
FIGURE 17 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF ONCOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
TOXICOLOGY
MARKET LEADERS
TABLE 35 LEADING MANUFACTURERS/SUPPLIERS OF INSTRUMENTS, ANALYZERS AND ASSAYS IN TOXICOLOGY BLOOD TESTING, 2013
MARKET SHARE
TABLE 36 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF TOXICOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013
FIGURE 18 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF TOXICOLOGY BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
OTHERS CATEGORY
MARKET LEADERS
TABLE 37 LEADING MANUFACTURERS/SUPPLIERS OF DEVICES, TEST STRIPS, AND ASSAYS IN OTHERS CATEGORY OF BLOOD TESTING, 2013
MARKET SHARE
TABLE 38 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THE OTHERS CATEGORY OF BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
FIGURE 19 MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THE OTHERS CATEGORY OF BLOOD TESTING DEVICES, INSTRUMENTS AND ASSAYS, 2013 (%)
CHAPTER 8 MARKET BY APPLICATION
BLOOD TESTS BY APPLICATION
GLOBAL BLOOD TESTING MARKET BY APPLICATION
TABLE 39 GLOBAL REVENUE FOR BLOOD TESTS BY APPLICATION AND END USER, THROUGH 2019 ($ MILLIONS)
FIGURE 20 GLOBAL REVENUE FOR BLOOD TESTS BY APPLICATION AND END USER, 2012-2019 ($ MILLIONS)
MARKET SHARE
TABLE 40 MARKET SHARE OF BLOOD TESTS BY APPLICATION AND END USER, 2013 (%)
FIGURE 21 MARKET SHARE OF BLOOD TESTS BY APPLICATION AND END USER, 2013 (%)
PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS
MARKET OVERVIEW
MARKET REVENUE
TABLE 41 GLOBAL REVENUE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, THROUGH 2019 ($ MILLIONS)
FIGURE 22 GLOBAL REVENUE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, 2012-2019 ($ MILLIONS)
MARKET SHARE
TABLE 42 MARKET SHARE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, 2013 (%)
FIGURE 23 MARKET SHARE OF PRESCRIPTION/DOCTOR OFFICE/CLINIC BLOOD TESTS, 2013 (%)
CANCER BLOOD TESTING
TABLE 43 DIFFERENT KINDS OF CANCER
Cancer Biomarker
TABLE 44 CANCER BIOMARKERS
Market Overview
Market Revenue
TABLE 45 GLOBAL REVENUE FOR CANCER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 24 GLOBAL REVENUE FOR CANCER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
BLOOD DISORDER BLOOD TESTING
TABLE 46 BLOOD DISORDERS
Market Overview
Market Revenue
TABLE 47 GLOBAL REVENUE FOR BLOOD DISORDER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 25 GLOBAL REVENUE FOR BLOOD DISORDER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
AUTOIMMUNE DISEASE AND FOOD ALLERGY TESTING
TABLE 48 AUTOIMMUNE DISEASES
Market Overview
Market Revenue
TABLE 49 GLOBAL REVENUE FOR AUTOIMMUNE DISEASE BLOOD TESTING AND FOOD ALLERGY BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 26 GLOBAL REVENUE FOR AUTOIMMUNE DISEASE BLOOD TESTING AND FOOD ALLERGY BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
CARDIOVASCULAR DISEASE BLOOD TESTING
TABLE 50 CARDIOVASCULAR DISEASES
Market Overview
Market Revenue
TABLE 51 GLOBAL REVENUE FOR CARDIOVASCULAR DISEASE BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 27 GLOBAL REVENUE FOR CARDIOVASCULAR DISEASE BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
KIDNEY DISORDER BLOOD TESTING
TABLE 52 KIDNEY DISORDERS
Market Overview
Market Revenue
TABLE 53 GLOBAL REVENUE FOR KIDNEY DISORDER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 28 GLOBAL REVENUE FOR KIDNEY DISORDER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
LIVER DISORDER BLOOD TESTING
Market Overview
Market Revenue
TABLE 54 GLOBAL REVENUE FOR LIVER DISORDER BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 29 GLOBAL REVENUE FOR LIVER DISORDER BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
PREGNANCY BLOOD TESTING
TABLE 55 INFECTIONS CAUSED BY MICROORGANISMS
Market Overview
Market Revenue
TABLE 56 GLOBAL REVENUE FOR PREGNANCY BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 30 GLOBAL REVENUE FOR PREGNANCY BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
DIABETES BLOOD TESTING
TABLE 57 TYPES OF DIABETES
Market Overview
Market Revenue
TABLE 58 GLOBAL REVENUE FOR DIABETES BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 31 GLOBAL REVENUE FOR DIABETES BLOOD TESTING BY REGION, 2012-2019 ($ MILLIONS)
FERTILITY BLOOD TESTING
Market Overview
Market Revenue
TABLE 59 GLOBAL REVENUE FOR FERTILITY BLOOD TESTING BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 32 GLOBAL REVENUE FOR FERTILITY BLOOD TESTS, BY REGION, 2012-2019 ($ MILLIONS)
HOME-MONITORING BLOOD TESTING
MARKET OVERVIEW
MARKET REVENUE
TABLE 60 GLOBAL REVENUE FOR HOME-MONITORING BLOOD TESTING, THROUGH 2019 ($ MILLIONS)
FIGURE 33 GLOBAL REVENUE FOR HOME-MONITORING BLOOD TESTING, 2012-2019 ($ MILLIONS)
MARKET SHARE
TABLE 61 MARKET SHARE OF HOME-MONITORING BLOOD TESTING, 2013 (%)
FIGURE 34 MARKET SHARE OF HOME-MONITORING BLOOD TESTING, 2013 (%)
DEVICES
TABLE 62 HOME-MONITORING DEVICES
Market Overview
Market Revenue
TABLE 63 GLOBAL REVENUE FOR HOME-MONITORING DEVICES BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 35 GLOBAL REVENUE FOR HOME-MONITORING DEVICES BY REGION, 2012-2019 ($ MILLIONS)
TEST STRIPS
Market Overview
Market Revenue
TABLE 64 GLOBAL REVENUE FOR HOME-MONITORING TEST STRIPS BY REGION, THROUGH 2019 ($ MILLIONS)
FIGURE 36 GLOBAL REVENUE FOR HOME-MONITORING TEST STRIPS BY REGION, 2012-2019 ($ MILLIONS)
CHAPTER 9 PATENT ANALYSIS
PATENTS BY YEAR
TABLE 65 NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
FIGURE 37 NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
PATENTS BY TYPE/CATEGORY
TABLE 66 NUMBER OF SIGNIFICANT PATENTS BY CATEGORY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
FIGURE 38 NUMBER OF SIGNIFICANT PATENTS BY CATEGORY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
PATENTS BY COMPANY
TABLE 67 NUMBER OF U.S. PATENTS BY COMPANY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
PATENTS BY COUNTRY
TABLE 68 NUMBER OF U.S. PATENTS BY COUNTRY, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
TABLE 69 PATENT SHARES BY COUNTRY, JANUARY 2010 TO SEPTEMBER 2014 (%)
PATENTS BY ASSIGNEE
TABLE 70 NUMBER OF U.S. PATENTS BY ASSIGNEE, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
FIGURE 39 NUMBER OF U.S. PATENTS BY ASSIGNEE, JANUARY 2010 TO SEPTEMBER 2014 (NO. OF PATENTS)
CHAPTER 10 CURRENT SITUATION
FACTORS AFFECTING BLOOD TESTING
THE IMPACT OF CHRONIC DISEASES AND INFECTIONS
THE IMPACT OF THE AGING POPULATION
THE IMPACT OF LIFESTYLE
THE IMPACT OF OBESITY
THE IMPACT OF HOME-MONITORING SYSTEMS AND NEW PRODUCTS
THE IMPACT OF MANUFACTURING TECHNOLOGIES
THE IMPACT OF PRICE CONTROLS
THE IMPACT OF REGULATORY PRESSURES
THE IMPACT OF SIMILAR DEVICES
THE IMPACT OF LICENSING AGREEMENTS
THE IMPACT OF MERGERS AND ACQUISITIONS
CHAPTER 11 COMPANY PROFILES
A. MENARINI DIAGNOSTICS LTD.
ABAXIS
ABBOTT LABORATORIES
AKERS BIOSCIENCES INC. (ABI)
ALERE INC.
ANDON HEALTH CO. LTD.
APEX BIOTECHNOLOGY CORP.
ARKRAY USA INC.
BAYER HEALTHCARE PHARMACEUTICALS
BECTON, DICKINSON AND CO. (BD)
BIOMERIEUX MARCY L'ETOILE
BIO-RAD LABORATORIES INC.
CEPHEID
DANAHER CORP.
DEXCOM INC.
GRIFOLS
HEMOSENSE INC.
HMD BIOMEDICAL INC.
HOFFMAN-LA ROCHE
HOLOGIC
IDEAL LIFE INC.
INFOPIA CO. LTD.
JOHNSON & JOHNSON
LIFESCAN INC.
LUMINEX CORP.
MEDTRONIC
NIPRO DIAGNOSTICS INC.
NOVA BIOMEDICAL CORP.
ORTHO CLINICAL DIAGNOSTICS
QIAGEN
SIEMENS AG
T2 BIOSYSTEMS
THERMO FISHER SCIENTIFIC INC.
TRINITY BIOTECH
CHAPTER 12 APPENDIX-ABBREVIATIONS

Blood Testing: Technology and Global Markets

The blood testing market totaled $49.5 billion in 2013 and reached to nearly $50 billion in 2014 This market is expected to grow $56.6 billion in 2019, with a compound annual growth rate (CAGR) of 2.6%.

This report provides:

An overview of the global markets and technologies for blood testing.

Analyses of global market trends, with data from 2012, 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.

Coverage of major blood test categories including hematology, molecular screening, toxicology, and also oncology biomarker tests and cardiology tests.

Information on the latest trends and innovations in the blood testing product pipeline as well as information on new approaches for screening.

Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.

Relevant patent analysis.

Profiles of major players in the blood testing market.


This study covers the blood tests that are used routinely for screening, monitoring and evaluating by using analyzers (including automated analyzers) and integrated systems. This report also covers home-monitoring devices and test strips and the associated calibration reagents. The report analyzes and assesses therapeutic and screening applications of blood tests for human conditions such as diabetes, heart disease, autoimmune disorders, cancer, blood disorders, hormonal imbalances, infection, and pregnancy. Excluded from this study are urinalysis, urine home diagnostic kits, and diagnostic testing such as imaging. This study also excludes veterinary blood tests and their analyzers.

The scope of this study is global. BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections, and market shares. The emerging markets discussed include countries such as India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand, and Canada, among others. The Europe and U.S. markets are also covered.

The report also examines the factors boosting the blood testing market as well as the hindering factors. Further, the pipeline products and companies that are leading the blood test diagnostic market in the research and development of blood tests are discussed.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;